Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide

被引：102

作者：

Rocha, Sandra ^{[1
]}

Thueneman, Andreas F. ^{[2
]}

Pereira, Maria do Carmo ^{[1
]}

Coelho, Manuel ^{[1
]}

Moehwald, Helmuth ^{[3
]}

Brezesinski, Gerald ^{[3
]}

机构：

[1] Univ Porto, Fac Engn, Dept Chem Engn, LEPAE, P-4200465 Oporto, Portugal

[2] Fed Inst Mat Res & Testing, D-12489 Berlin, Germany

[3] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany

来源：

BIOPHYSICAL CHEMISTRY | 2008年 / 137卷 / 01期

关键词：

amyloid beta-peptide; circular dichroism; conformation analysis; electron microscopy; fluorinated complexes; nanoparticles;

D O I：

10.1016/j.bpc.2008.06.010

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Peptide aggregation in amyloid fibrils is implicated in the pathogenesis of several diseases such as Alzheimer's disease. There is a strong correlation between amyloid fibril formation and a decrease in conformational stability of the native state. Amyloid-P peptide (A beta), the aggregating peptide in Alzheimer's disease, is natively unfolded. The deposits found in Alzheimer's disease are composed of A beta fibrillar aggregates rich in beta-sheet structure. The influence of fluorinated complexes on the secondary structure and fibrillogenesis of A beta peptide was studied by circular dichroism, (CD) spectroscopy and transmission electron microscopy (TEM). CD spectra show that complexes of polyampholyte and fluorinated dodecanoic acid induce alpha-helix structure in A beta, but their hydrogenated analogous lead to beta-sheet formation and aggregation, The fluorinated nanoparticles with highly negative zeta potential and hydrophobic fluorinated core have the fundamental characteristics to prevent: A beta fibrillogenesis. (c) 2008 Elsevier B.V. All rights reserved.

引用

页码：35 / 42

页数：8

共 50 条

[1] SEQUESTRATION OF AMYLOID BETA-PEPTIDE
GOLDGABER, D
SCHWARZMAN, AI
BHASIN, R
GREGORI, L
SCHMECHEL, D
SAUNDERS, AM
ROSES, AD
STRITTMATTER, WJ
ALZHEIMERS DISEASE: AMYLOID PRECUSOR PROTEINS, SIGNAL TRANSDUCTION, AND NEURONAL TRANSPLANTATION, 1993, 695 : 139 - 143
[2] SOLUTION STRUCTURE OF RESIDUES-1-28 OF THE AMYLOID BETA-PEPTIDE
TALAFOUS, J
MARCINOWSKI, KJ
KLOPMAN, G
ZAGORSKI, MG
BIOCHEMISTRY, 1994, 33 (25) : 7788 - 7796
[3] STRUCTURAL DETERMINANTS OF THE ALZHEIMERS AMYLOID BETA-PEPTIDE
SOTO, C
BRANES, MC
ALVAREZ, J
INESTROSA, NC
JOURNAL OF NEUROCHEMISTRY, 1994, 63 (04) : 1191 - 1198
[4] Nicotine inhibits amyloid formation by the beta-peptide
Salomon, AR
Marcinowski, KJ
Friedland, RP
Zagorski, MG
BIOCHEMISTRY, 1996, 35 (42) : 13568 - 13578
[5] The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation
Golabek, AA
Soto, C
Vogel, T
Wisniewski, T
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) : 10602 - 10606
[6] THE SOLUTION STRUCTURE OF THE AMYLOID BETA-PEPTIDE DISPLAYS A STRIKING RESEMBLANCE TO ALAMETHICIN AND MELLITIN
ZAGORSKI, MG
TALAFOUS, JA
MARCINOWSKI, KJ
KLOPMAN, G
NEUROBIOLOGY OF AGING, 1994, 15 : S48 - S48
[7] SECONDARY STRUCTURE OF AMYLOID BETA-PEPTIDE CORRELATES WITH NEUROTOXIC ACTIVITY IN-VITRO
SIMMONS, LK
MAY, PC
TOMASELLI, KJ
RYDEL, RE
FUSON, KS
BRIGHAM, EF
WRIGHT, S
LIEBERBURG, I
BECKER, GW
BREMS, DN
LI, WY
MOLECULAR PHARMACOLOGY, 1994, 45 (03) : 373 - 379
[8] The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.
Golabek, AA
Soto, C
Wisniewski, T
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (05): : 150 - 150
[9] Amyloid beta-peptide and the dementia of Parkinson's disease
Jendroska, K
Lees, AJ
Poewe, W
Daniel, SE
MOVEMENT DISORDERS, 1996, 11 (06) : 647 - 653
[10] Role of membrane sphingolipids in the interaction with amyloid beta-peptide
Carrotta, R.
Librizzi, F.
Mangione, M. R.
Vilasi, S.
Cossu, C.
Moran, O.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S300 - S300

← 1 2 3 4 5 →